CompletedNot Applicable

Head and Neck Cancer Patient Symptom and Oncologic Outcomes

United States13 participantsStarted 2023-03-31

Plain-language summary

This trial investigates a new approach using a mobile three-dimensional (3D) scanning application for volumetric measurement of the head and neck region in patients with head and neck lymphedema. Lymphedema is the buildup of extra lymph fluid in tissues that causes swelling. Accurate volumetric measurements of swelling are crucial to the diagnosis of lymphedema and to monitoring response to therapy and disease progression over time. A mobile 3D surface scanning application may help doctors measure and analyze swelling in patients with head and neck lymphedema.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with pathologies leading to head and neck lymphedema * Individuals with minimal or no facial hair * Patients of sound mentation, who are able to execute informed decision-making Exclusion Criteria: * Any health conditions or history of non-compliance that affect the study will preclude study participation

What they're measuring

Volume of interest between the cutting planes

Timeframe: Up to 24 weeks

Average values of the two repeated scans

Timeframe: Up to 24 weeks

Patient wellbeing/disease progression

Timeframe: Up to 24 weeks

Trial details

NCT IDNCT05243069

SponsorOhio State University Comprehensive Cancer Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-03-02

View on ClinicalTrials.gov More Lymphedema of the Head and Neck trials